Workflow
蒙草生态(300355) - 2023 Q3 - 季度财报
MCSTMCST(SZ:300355)2023-10-24 16:00

Financial Performance - The company's operating revenue for Q3 2023 was CNY 487,519,120.22, an increase of 18.43% compared to the same period last year[5]. - The net profit attributable to shareholders was CNY 111,609,729.51, representing a significant increase of 143.88% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 102,187,143.72, up by 2402.44% compared to the previous year[5]. - The company reported a net profit of CNY 303,560,371.32 for the period, a year-on-year increase of 63.31%[9]. - The net profit for Q3 2023 was CNY 303,560,371.32, a significant increase from CNY 185,881,620.50 in Q3 2022, representing a growth of approximately 63.4%[25]. - Operating profit for Q3 2023 reached CNY 361,668,007.89, compared to CNY 219,583,772.43 in the same period last year, indicating a year-over-year increase of about 64.4%[25]. - The total profit before tax for Q3 2023 was CNY 358,948,027.46, up from CNY 211,745,147.60 in Q3 2022, reflecting an increase of about 69.5%[25]. Cash Flow and Assets - The cash flow from operating activities for the year-to-date was CNY 1,439,745,875.58, an increase of 1054.04%[5]. - Cash received from sales and services rose by 78.40% to CNY 2,609,003,903.77, primarily due to the company's PPP projects entering the payment phase[10]. - The total cash and cash equivalents at the end of Q3 2023 were CNY 849,492,841.72, compared to CNY 381,434,914.33 at the end of Q3 2022, indicating a significant increase of approximately 123.5%[28]. - The company's cash and cash equivalents increased by 81.51% to CNY 969,902,772.66 due to significant collections from accounts receivable[9]. - The cash flow from operating activities for Q3 2023 was CNY 1,439,745,875.58, a substantial rise from CNY 124,756,923.75 in Q3 2022[28]. - The company experienced a net cash outflow from investing activities of CNY 29,696,439.52 in Q3 2023, contrasting with a net inflow of CNY 42,679,617.29 in Q3 2022[28]. Assets and Liabilities - The total assets at the end of Q3 2023 were CNY 15,415,091,443.19, a decrease of 3.99% from the end of the previous year[5]. - Total current assets decreased to CNY 6,524,170,307.84 from CNY 7,138,829,077.24, a reduction of 8.6%[22]. - Total liabilities decreased to CNY 9,396,676,081.03 from CNY 10,311,957,832.68, a decline of 8.8%[23]. - The non-current liabilities decreased to CNY 3,956,535,133.10 from CNY 4,468,826,154.99, a decline of 11.5%[23]. - The company's equity increased to CNY 6,018,415,362.16 from CNY 5,743,581,348.28, an increase of 4.8%[23]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 61,097, with no preferred shareholders[12]. - The largest shareholder, Wang Zhaoming, holds 16.78% of the shares, totaling 269,131,442 shares[12]. Research and Development - Research and development expenses rose by 44.03% to CNY 94,302,483.33, driven by increased investment in special research projects[9]. - Research and development expenses increased to CNY 94,302,483.33 in Q3 2023, up from CNY 65,473,677.92 in Q3 2022, reflecting a rise of approximately 43.9%[25]. - The deferred income increased by 125.38% to CNY 358,618,451.84, attributed to a significant rise in government grants for research projects[9]. - Government subsidies related to research increased significantly, with cash received from operating activities rising by 494.62% to CNY 289,036,263.70[10]. Investment Activities - Investment income surged by 1113.36% to CNY 9,866,537.71, attributed to dividends received from associated companies[10]. - The company made an investment payment of CNY 15,850,000.00 during the reporting period for equity stakes in associated companies[10]. - Cash received from the disposal of subsidiaries increased by 220.66% to CNY 12,826,350.00, due to contractual agreements related to previous disposals[10]. - Cash paid for the purchase of fixed assets increased by 136.26% to CNY 68,131,889.18, reflecting investments in research project equipment and seed production rights[10]. Taxation - The company's income tax expense increased by 114.15% to CNY 55,387,656.14 due to higher profits during the reporting period[10]. - The company reported a significant decrease of 98.51% in tax refunds received, down to CNY 1,136,025.56, compared to the previous year[10].